Merakris Therapeutics is a North Carolina-based biotech company focused on regenerative medicine, specifically wound care for indications like diabetic foot and venous stasis ulcers. Merakris aims to develop effective therapies that require fewer treatments and improve patient outcomes while reducing healthcare costs. Instead of using whole cells, they utilize cell-derived signaling proteins and nano vesicles to promote healing. Currently, they are investigating the use of amniotic fluid exosomes and soluble proteins to activate the epithelial to mesenchymal transition and mesenchymal to epithelial transition, supporting early- and late-stage healing and keratinization. They’ve also developed an amniotic stem cell co-culture platform for the creation of targeted therapeutic formulations.

Merakris Therapeutics

Founded: 2016
Location: Durham, NC
Employee range: 11 - 50
Funding: not disclosed

Short description:

Drug notes:

Long description:

Jobs: